CALDERON SANCHEZ, EVA MARIA, Delgado, Carmen , Ruiz-Hurtado, Gema , Dominguez-Rodriguez, Alejandro , Cachofeiro, Victoria , Rodriguez-Moyano, Maria , Maria Gomez, Ana , Ordonez, Antonio , Smani, Tarik
No
Cardiovasc. Res.
Article
Científica
5.801
2.972
01/09/2009
000269014100016
The aim of this study is to evaluate the positive inotropic effect of urocortin (Ucn) and to characterize its signalling pathways. Contractility was measured in ex vivo Langendorff-perfused hearts isolated from Wistar rats. Isolated ventricular cardiomyocytes were used to analyse intracellular calcium ([Ca2+](i)) transients evoked by electrical stimulation and L-type Ca2+ current by confocal microscopy and whole-cell patch-clamping, respectively. The application of Ucn to perfused hearts induced progressive, sustained, and potent inotropic and lusitropic effects that were dose-dependent with an EC50 of approximately 8 nM. Ucn effects were independent of protein kinase A (PKA) activation but were significantly reduced by protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) inhibitors and by brefeldin A, an antagonist of guanine nucleotide exchange factor, suggested to be an inhibitor of exchange protein activated by cAMP (Epac). These whole-organ effects were correlated with the inotropic effects observed in isolated cells: Ucn increased I-CaL density, [Ca2+](i) transients, cell shortening and Ca2+ content of sarcoplasmic reticulum. Our results show that Ucn evokes potent positive inotropic and lusitropic effects mediated, at least in part, by an increase in I-CaL and [Ca2+](i) transient amplitude. These effects may involve the activation of Epac, PKC, and MAPK signalling pathways.
Urocortin; Inotropic; PKC; ERK1; 2; Epac; Ca2+